TCL Archive Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala June 18, 1993
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds November 28, 1975
